Publications by authors named "Gils Roex"

Claim this Profile
E
Expanding the CAR toolbox with high throughput screening strategies for CAR domain exploration: a comprehensive review.
Gils Roex, Khloe S Gordon, Eva Lion, Michael E Birnbaum, Sébastien Anguille

J Immunother Cancer· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IL-15-secreting CAR natural killer cells directed toward the pan-cancer target CD70 eliminate both cancer cells and cancer-associated fibroblasts.
Astrid Van den Eynde, Laura Gehrcken, Tias Verhezen, Ho Wa Lau, Christophe Hermans, Gils Roex

J Hematol Oncol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
One-step CRISPR-Cas9-mediated knockout of native TCRαβ genes in human T cells using RNA electroporation.
Donovan Flumens, Diana Campillo-Davo, Ibo Janssens, Gils Roex, Jorrit De Waele

STAR Protoc· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chimeric antigen receptor clustering via cysteines enhances T-cell efficacy against tumor.
Yuedi Wang, Yiyuan Gao, Congyi Niu, Bo Wang, Shushu Zhao, Gils Roex

Cancer Immunol Immunother· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Two for one: targeting BCMA and CD19 in B-cell malignancies with off-the-shelf dual-CAR NK-92 cells.
Gils Roex, Diana Campillo-Davo, Donovan Flumens, Philip Anthony Gilbert Shaw, Laurens Krekelbergh

J Transl Med· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Ins and Outs of Messenger RNA Electroporation for Physical Gene Delivery in Immune Cell-Based Therapy.
Diana Campillo-Davo, Maxime De Laere, Gils Roex, Maarten Versteven, Donovan Flumens

Pharmaceutics· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and clinical efficacy of BCMA CAR-T-cell therapy in multiple myeloma.
Gils Roex, Marijke Timmers, Kristien Wouters, Diana Campillo-Davo, Donovan Flumens

J Hematol Oncol· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chimeric Antigen Receptor-Modified T Cell Therapy in Multiple Myeloma: Beyond B Cell Maturation Antigen.
Marijke Timmers, Gils Roex, Yuedi Wang, Diana Campillo-Davo, Viggo F I Van Tendeloo

Front Immunol· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chimeric Antigen Receptor-T-Cell Therapy for B-Cell Hematological Malignancies: An Update of the Pivotal Clinical Trial Data.
Gils Roex, Tom Feys, Yves Beguin, Tessa Kerre, Xavier Poiré

Pharmaceutics· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rapid Assessment of Functional Avidity of Tumor-Specific T Cell Receptors Using an Antigen-Presenting Tumor Cell Line Electroporated with Full-Length Tumor Antigen mRNA.
Diana Campillo-Davo, Maarten Versteven, Gils Roex, Hans De Reu, Sanne van der Heijden

Cancers (Basel)· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dendritic Cell-Based Immunotherapy of Acute Myeloid Leukemia.
Heleen H Van Acker, Maarten Versteven, Felix S Lichtenegger, Gils Roex, Diana Campillo-Davo

J Clin Med· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of the common gamma-chain family cytokines in γδ T cell-based anti-cancer immunotherapy.
Heleen H Van Acker, Diana Campillo-Davo, Gils Roex, Maarten Versteven, Evelien L Smits

Cytokine Growth Factor Rev· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis